Ellen van der Spek
Overview
Explore the profile of Ellen van der Spek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hesius E, Stevens W, Stewart J, Kroeze L, Spek E, Issa D, et al.
J Clin Pathol
. 2025 Jan;
PMID: 39890445
Aims: Follicular lymphoma (FL) is characterised by significant heterogeneity in both the clinical trajectories and the molecular profiles. This study aimed to investigate clonal dynamics in FL by analysing mutation...
2.
Smits F, Smits F, Groen K, Levin M, Stege C, Stege C, et al.
Blood
. 2024 Nov;
145(5):543-546.
PMID: 39576961
The level of frailty, according to the International Myeloma Working Group frailty index, is highly dynamic during antimyeloma treatment. Dynamic frailty assessment improved the prediction of survival and early mortality...
3.
Mennens S, Spek E, Ruinemans-Koerts J, Van Borren M
Case Rep Hematol
. 2024 Aug;
2024:8844335.
PMID: 39189035
We present a patient at risk of misdiagnosis with multiple myeloma due to pseudohypercalcemia. Examinations showed monoclonal protein, 50% monoclonal plasma cells in bone marrow, and hypercalcemia but no osteolytic...
4.
Groen K, Smits F, Nasserinejad K, Levin M, Regelink J, Timmers G, et al.
Hemasphere
. 2024 Jul;
8(7):e85.
PMID: 38966208
No abstract available.
5.
Langerbeins P, Giza A, Robrecht S, Cramer P, von Tresckow J, Al-Sawaf O, et al.
Am J Hematol
. 2024 May;
99(8):1620-1623.
PMID: 38757754
No abstract available.
6.
Berendsen M, van Bladel D, Hesius E, Berganza Irusquieta C, Rijntjes J, Spriel A, et al.
Hemasphere
. 2023 Nov;
7(11):e976.
PMID: 37928625
Patients with lymphoplasmacytic lymphoma/Waldenström macroglobulinemia (LPL/WM) occasionally develop diffuse large B-cell lymphoma (DLBCL). This mostly results from LPL/WM transformation, although clonally unrelated DLBCL can also arise. LPL/WM is characterized by...
7.
Visentin A, Chatzikonstantinou T, Scarfo L, Kapetanakis A, Demosthenous C, Karakatsoulis G, et al.
Am J Hematol
. 2023 Sep;
98(12):1856-1868.
PMID: 37772428
In this retrospective international multicenter study, we describe the clinical characteristics and outcomes of patients with chronic lymphocytic leukemia (CLL) and related disorders (small lymphocytic lymphoma and high-count monoclonal B...
8.
Groen K, Stege C, Nasserinejad K, de Heer K, van Kampen R, Leys R, et al.
EClinicalMedicine
. 2023 Sep;
63:102167.
PMID: 37680948
Background: The outcome of non-transplant eligible newly diagnosed multiple myeloma (NDMM) patients is heterogeneous, partly depending on frailty level. The aim of this study was to prospectively investigate the efficacy...
9.
Groen K, Schjesvold F, van der Holt B, Levin M, Seefat M, Hansson M, et al.
Hemasphere
. 2023 Sep;
7(9):e940.
PMID: 37663673
No abstract available.
10.
van Bladel D, Stevens W, Kroeze L, de Groen R, de Groot F, van der Last-Kempkes J, et al.
Blood Adv
. 2023 Aug;
7(19):5911-5924.
PMID: 37552109
Despite high cure rates in classic Hodgkin lymphoma (cHL), relapses are observed. Whether relapsed cHL represents second primary lymphoma or an underlying T-cell lymphoma (TCL) mimicking cHL is underinvestigated. To...